Pma/510(k)#: p100022/s001.Fda mdr report required based on the surgical interventions [bypass and poba] carried out and the subsequent permanent impairment of the patient [amputation of left lower limb ] following the restenosis of the limb where a zilver ptx stent was indwelling.The ziv6-35-125-6.0-120-ptx stent of lot number c791324 was implanted in the patient therefore is not available for evaluation.With the information provided a document based investigation was carried out.It was confirmed that images would not be available to support the complaint investigation and no other information could be provided.It can be noted stenosis of the lower limb followed by occlusion of the by-pass, may suggest progressing artery disease.This can be associated with the restenosis process.However, a definitive cause of this event cannot be determined.There is no evidence to suggest that this event did not occur; therefore the complaint is confirmed based on customer testimony.It can be noted that bypass, amputation of foot and restenosis of the stented artery are a known potential adverse event associated with placement of this device.Prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.A review of the relevant manufacturing records revealed no discrepancies that could have contributed to this complaint.No information regarding patient outcome was provided.Quality engineering will continue to monitor complaints of this nature for potential emerging trends.
|